Martin Fan
Stock Analyst at Wedbush
(4.85)
# 72
Out of 5,245 analysts
34
Total ratings
60.71%
Success rate
76.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Maintains: Neutral | $15 → $18 | $14.33 | +25.61% | 3 | May 14, 2026 | |
| IMA ImageneBio | Reiterates: Underperform | $2 | $5.56 | -64.03% | 2 | May 11, 2026 | |
| NKTR Nektar Therapeutics | Maintains: Neutral | $95 → $80 | $66.61 | +20.10% | 3 | May 11, 2026 | |
| ARTV Artiva Biotherapeutics | Maintains: Outperform | $23 → $40 | $7.87 | +408.26% | 3 | May 11, 2026 | |
| RNAC Cartesian Therapeutics | Reiterates: Outperform | $38 | $6.76 | +462.13% | 3 | May 1, 2026 | |
| ACRS Aclaris Therapeutics | Maintains: Outperform | $8 → $10 | $4.52 | +121.24% | 3 | Apr 29, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Outperform | $45 → $85 | $60.61 | +40.24% | 4 | Apr 15, 2026 | |
| SANA Sana Biotechnology | Maintains: Outperform | $6 → $7 | $3.07 | +128.01% | 3 | Apr 14, 2026 | |
| ANAB AnaptysBio | Maintains: Outperform | $60 → $75 | $59.71 | +25.61% | 6 | Mar 12, 2026 | |
| ZURA Zura Bio | Initiates: Outperform | $15 | $4.36 | +244.04% | 1 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $45 | $18.97 | +137.22% | 3 | Dec 22, 2025 |
Vor Biopharma
May 14, 2026
Maintains: Neutral
Price Target: $15 → $18
Current: $14.33
Upside: +25.61%
ImageneBio
May 11, 2026
Reiterates: Underperform
Price Target: $2
Current: $5.56
Upside: -64.03%
Nektar Therapeutics
May 11, 2026
Maintains: Neutral
Price Target: $95 → $80
Current: $66.61
Upside: +20.10%
Artiva Biotherapeutics
May 11, 2026
Maintains: Outperform
Price Target: $23 → $40
Current: $7.87
Upside: +408.26%
Cartesian Therapeutics
May 1, 2026
Reiterates: Outperform
Price Target: $38
Current: $6.76
Upside: +462.13%
Aclaris Therapeutics
Apr 29, 2026
Maintains: Outperform
Price Target: $8 → $10
Current: $4.52
Upside: +121.24%
Oruka Therapeutics
Apr 15, 2026
Maintains: Outperform
Price Target: $45 → $85
Current: $60.61
Upside: +40.24%
Sana Biotechnology
Apr 14, 2026
Maintains: Outperform
Price Target: $6 → $7
Current: $3.07
Upside: +128.01%
AnaptysBio
Mar 12, 2026
Maintains: Outperform
Price Target: $60 → $75
Current: $59.71
Upside: +25.61%
Zura Bio
Feb 9, 2026
Initiates: Outperform
Price Target: $15
Current: $4.36
Upside: +244.04%
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $18.97
Upside: +137.22%